Myolastan



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 100.0%
Dermatitis Contact 66.7%
Bone Marrow Failure 33.3%
Secondary
Product Used For Unknown Indication 22.6%
Drug Use For Unknown Indication 21.4%
Back Pain 10.8%
Hypertension 5.0%
Sciatica 4.6%
Type 2 Diabetes Mellitus 3.9%
Parkinson's Disease 3.5%
Pain 3.3%
Ill-defined Disorder 2.9%
Anaesthesia 2.7%
Arthralgia 2.5%
Dyslipidaemia 2.3%
Psoriatic Arthropathy 2.3%
Diabetes Mellitus 2.1%
Neuralgia 2.1%
Infection Prophylaxis 1.9%
Multiple Myeloma 1.9%
Depression 1.7%
Prophylaxis 1.5%
Myalgia 1.2%
Pathological Fracture 14.7%
Toxic Skin Eruption 9.3%
Malaise 6.7%
Renal Failure Acute 6.7%
Rash Papular 5.3%
Somnolence 5.3%
Toxic Epidermal Necrolysis 5.3%
Wegener's Granulomatosis 5.3%
Acute Generalised Exanthematous Pustulosis 4.0%
Hepatitis Cholestatic 4.0%
Pierre Robin Syndrome 4.0%
Pyrexia 4.0%
Septic Shock 4.0%
Stevens-johnson Syndrome 4.0%
Vomiting 4.0%
Cytolytic Hepatitis 2.7%
Dermatitis Exfoliative 2.7%
Erythema Multiforme 2.7%
Grand Mal Convulsion 2.7%
Lichenoid Keratosis 2.7%
Concomitant
Drug Use For Unknown Indication 19.4%
Product Used For Unknown Indication 11.2%
Pain 9.9%
Prophylaxis 8.0%
Rheumatoid Arthritis 6.7%
Back Pain 5.7%
Osteoporosis 4.0%
Hypertension 3.5%
Depression 3.4%
Unevaluable Event 3.0%
Breast Cancer 2.9%
Thrombosis Prophylaxis 2.9%
Non-small Cell Lung Cancer 2.7%
Bone Pain 2.6%
Anxiety 2.5%
Neuralgia 2.5%
Multiple Myeloma 2.4%
Insomnia 2.2%
Pseudomonas Infection 2.2%
Staphylococcal Infection 2.2%
Vomiting 11.1%
Pulmonary Embolism 7.1%
Confusional State 6.1%
Rectal Haemorrhage 6.1%
Neutropenia 5.1%
Pancytopenia 5.1%
Pyrexia 5.1%
Renal Failure Acute 5.1%
Sepsis 5.1%
Tachycardia 5.1%
Thrombocytopenic Purpura 5.1%
Aortic Aneurysm 4.0%
Haematoma 4.0%
Hepatocellular Injury 4.0%
Hypertension 4.0%
Tendon Rupture 4.0%
Weight Decreased 4.0%
Weight Increased 4.0%
Deep Vein Thrombosis 3.0%
General Physical Health Deterioration 3.0%
Interacting
Product Used For Unknown Indication 25.0%
Depression 16.7%
Muscle Contracture 16.7%
Sciatica 16.7%
Drug Use For Unknown Indication 8.3%
Dysthymic Disorder 8.3%
Hypertension 8.3%
Dizziness 20.0%
Drug Interaction 20.0%
Hypoxic-ischaemic Encephalopathy 20.0%
International Normalised Ratio Increased 20.0%
Orthostatic Hypotension 20.0%